We are live on ! Find out more
AC

Aldebaran Capital Portfolio holdings

AUM $131M
1-Year Est. Return 34.7%
This Fund
S&P 500
This Quarter Est. Return
+10.94%
1 Year Est. Return
+34.7%
3 Year Est. Return
+72.53%
5 Year Est. Return
10 Year Est. Return
AUM
$109M
AUM Growth
+$7.53M
Cap. Flow
-$992K
Cap. Flow %
-0.91%
Top 10 Hldgs %
71.12%
Holding
35
New
1
Increased
2
Reduced
24
Closed
2

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$1.01M
2
GEV icon
GE Vernova
GEV
+$201K
3
FCX icon
Freeport-McMoran
FCX
+$36K

Sector Composition

Rank Sector Weight
1 Financials 29.51%
2 Energy 17.75%
3 Healthcare 11.19%
4 Technology 10.33%
5 Consumer Staples 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DUK icon
26
Duke Energy
DUK
$98.4B
$446K 0.41%
3,600
GE icon
27
GE Aerospace
GE
$368B
$378K 0.35%
1,256
F icon
28
Ford
F
$59.3B
$337K 0.31%
28,150
MBIN icon
29
Merchants Bancorp
MBIN
$2.55B
$322K 0.3%
10,125
GEV icon
30
GE Vernova
GEV
$262B
$204K 0.19%
+332
New +$201K
IMA
31
ImageneBio Inc
IMA
$67.2M
$159K 0.15%
19,562
-614
-3% -$8.14K
OKUR
32
OnKure Therapeutics
OKUR
$162M
$121K 0.11%
43,997
-176
-0.4% -$436
EPIX
33
DELISTED
ESSA Pharma
EPIX
-578,939
Closed -$984K
PG icon
34
Procter & Gamble
PG
$335B
-1,260
Closed -$201K

Similar funds

Aldebaran Capital's Q3 2025 Portfolio in Review

As of Q3 2025, Aldebaran Capital held 35 positions worth $109M, up 7.4% from $101M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Aldebaran Capital's Q3 2025 filing shows 1 new, 2 increased, 24 reduced and 2 closed positions. Its largest new stake was GE Vernova: 332 shares worth $204K. The largest sale was ESSA Pharma, an estimated $984K.

By sector, the portfolio is most concentrated in Financials at 30% of assets, down from 31% a quarter earlier, followed by Energy and Healthcare.

  • Aldebaran Capital's largest Q3 2025 buy was GE Vernova: 332 shares worth $204K.
  • Aldebaran Capital added most to Verizon in Q3 2025, an estimated $1.01M increase.
  • Aldebaran Capital's biggest Q3 2025 reduction was Berkshire Hathaway Class B, cutting an estimated $131K.
  • Aldebaran Capital fully exited ESSA Pharma in Q3 2025, selling an estimated $984K.
  • Aldebaran Capital's ten largest holdings make up 71% of its $109M portfolio in Q3 2025.
  • Aldebaran Capital opened 1 new position and closed 2 in Q3 2025.
  • Aldebaran Capital's portfolio value rose 7.4% quarter-over-quarter to $109M.

Based on Aldebaran Capital's 13F filing for Q3 2025, filed 10 Nov 2025.